// App-Quantinova.ai

: ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report

Researchers

Presenter

  • Sabina Chiaretti

Principal Investigators

  • Roberta Agrippino

  • Mario Annunziata

  • Anna Candoni

  • Cerrano Marco

  • Michele Cedrone

  • Maria Ciccone

  • Patrizia Chiusolo

  • Antonio Curti

  • Michelina Dargenio

  • Marzia Defina

  • Mario Delia

  • Maria Ilaria Del Principe

  • Mauro Endri

  • Carmen Fava

  • Fabio Forghieri

  • Alessandro Fiorentini

  • Fabio Giglio

  • Francesco Grimaldi

  • Fabio Guolo

  • Michela Lamanda

  • Monia Lunghi

  • Federico Lussana

  • Valentina Mancini

  • Carla Mazzone

  • Antonino Mule

  • Crescenza Pasciolla

  • Matteo Piccini

  • Giovanna Rege Cambrin

  • Prassede Salutari

  • Lidia Santoro

  • Anna Maria Scattolin

  • Mariarita Sciume

  • Elisabetta Todisco

  • Felicetto Ferrara

  • Giovanni Pizzolo

  • Robin Foa

Medical Centers

  • Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy

  • Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma, Rome, Italy

  • ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

  • Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

  • Section of Hematology, Department of Surgical and Medical Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy

  • Complex Operative Unit of Haematology, dell'Angelo Hospital and Santissimi Giovanni and Paolo Hospital, Venezia Mestre, Italy

  • Hematology Unit, Azienda Ospedaliera Cardarelli, Naples, Italy

  • University of Turin, ORBASSANO TORINO, Italy

  • Ospedali Riuniti Marche nord, Ancona, Italy

  • Ematologia, Dipartimento di Biomedicina e Prevenzione, Università degli studi di Roma Tor Vergata, Roma, Italy

  • Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy

  • Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

  • Azienda Ospedaliero-Universitaria di Ferrara, ferrara, Italy

  • Haematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • Division of Hematology and Bone Marrow Transplantation, Clinica Di Ematologia E Unità Di Terapie Cellulari 'carlo Melzi'-Azienda, Udine, Italy

  • UOC Ematologia - Ospedale Ca' Foncello - Treviso, treviso, Italy

  • Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy

  • Division of Hematology Department of Translational Medicine, AOU Maggiore della Carità, Università del Piemonte Orientale, Novara, ITA

  • University of Naples Federico II, Naples, Italy, Napoli, ITA

  • Hematology and Stem Cell Transplantation Unit, Vito Fazzi Hospital, Lecce, Italy

  • Hematology and Stem Cell Transplantation Unit - A.O.U. Consorziale Policlinico di Bari, Bari, Italy

  • Hematology, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy

  • Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy

  • Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy

  • IEO, European Institute of Oncology IRCCS, Milan, Milan, Italy

  • Azienda ospedaliero-universitaria Careggi, Department of Hematology, Florence, Italy

  • Division of Hematology and Bone Marrow Transplantation, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy

  • Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, ITA

  • Dipartimento Oncologia Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy

  • San Giovanni - Addolorata Hospital, ROMA CAPITALE, ITA

  • Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

Disease

  • Acute lymphoblastic leukemia

  • Coronavirus disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A